Answer:
See below
Explanation:
A) First of all, it must be considered that HIV has a RNA genome.
The reverse transcriptase is a viral enzyme able to convert a RNA molecule (in this case the RNA would be the viral genome) to DNA. This process is important for two reasons:
* The DNA molecule is more stable than RNA --> Therefore, there is a higher likely that the molecule wouldn't be degradated by the host.
* The viral genome made of DNA will be integrated into the host genome --> To do so, it requires to be DNA instead of RNA
B) The inibitor is able to target the Reverse Transcriptase --> So, the likehood of converting RNA to DNA is lower. In this case, the single RNA molecule is less stable than the DNA and the host can degradate it more easily.
C) In general, the viral will not survive the treatment and, hence, the patient will not suffer from the viral infection